Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease
NCT07802210 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-09-03
Summary
Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025).
Patients with sickle cell disease suffer from various complications of the disease during their lifetime, including anemia, sickle cell crises, acute chest syndrome, stroke, renal failure, retinal detachment and priapism. However, unforeseen and chronic pain crisis are the most common symptoms reported by the patients which are considered as the most common causes of referral to the emergency department and hospital to receive medical care in sickle cell patients (Poku, Atkin,\& Kirk,.2023).
Objective(s) of the study:
1. To evaluate the effectiveness of Innovative Educational Methods on self-efficacy in children with sickle cell anemia.
2. To evaluate the effectiveness of Innovative Educational Methods on self-care capacity in children with sickle cell anemia.
3. To find out the relationship between the effectiveness of Innovative Educational Methods on self-efficacy, self-care capacity and demographic characteristics of children with sickle cell anemia.
Conditions
- Sickle Cell Anemia in Children
Interventions
- OTHER
-
video intervention
Participants in this group will watch an educational video lasting under 5 minutes. The video covers key information about anemia, including its definition, pathophysiology, symptoms, underlying causes, potential complications, and preventive pain crisis in simple way by use AI programs to generation it ."
- OTHER
-
game intervention
Participants in this group will play an educational game . The game covers key information about anemia, including its definition, pathophysiology, symptoms, underlying causes, potential complications, and preventive pain crisis in simple way by use AI programs to generation it .
Sponsors & Collaborators
-
Aula Ibrahim abd alrazak
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 11 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2026-12-01
- Completion
- 2026-12-01
Countries
- Iraq
Study Locations
More Related Trials
-
Improving Self-Management in Adolescents With Sickle Cell Disease
NCT02851615 ·Status: COMPLETED ·Phase: NA
-
Effects of HQK-1001 in Patients With Sickle Cell Disease
NCT01601340 ·Status: TERMINATED ·Phase: PHASE2
-
Sickle Cell Disease (SCD) Decision Aid
NCT03224429 ·Status: COMPLETED ·Phase: NA
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Outcomes of Vaso-occlusive Crisis in Pediatric Sickle Cell Disease
NCT07200869 ·Status: NOT_YET_RECRUITING
-
Study of Hydroxyurea to Treat Sickle Cell Disease
NCT02868138 ·Status: COMPLETED
-
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
NCT00895154 ·Status: COMPLETED ·Phase: NA
-
Integrative Training Program for Pediatric Sickle Cell Pain
NCT06691867 ·Status: RECRUITING ·Phase: NA
-
Transcranial Photobiomodulation Treatment in Patients With Sickle Cell Disease
NCT06797583 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Pressure Pain Tolerance in Relation to Balance and Strength in Children
NCT06529874 ·Status: RECRUITING ·Phase: NA
-
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
NCT06023199 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease
NCT04877054 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Improvement: Enhancing Care in the Emergency Department
NCT05373771 ·Status: RECRUITING ·Phase: NA
-
A Study of HQK-1001 in Patients With Sickle Cell Disease
NCT01322269 ·Status: COMPLETED ·Phase: PHASE2
-
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)
NCT03380351 ·Status: COMPLETED
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: COMPLETED ·Phase: NA
-
The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell Hemoglobin C Disease (SC)
NCT07277023 ·Status: COMPLETED ·Phase: NA
-
Sickle Cell Clinical Research and Intervention Program
NCT02098863 ·Status: RECRUITING
-
Vascular Function Intervention Trial in Sickle Cell Disease
NCT01718054 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Sickle Cell Pro-Inflammatory Response to Interval Training Study
NCT03653676 ·Status: COMPLETED
-
A Study to Learn About Sickle Cell Disease In Adult Patients
NCT05407805 ·Status: COMPLETED
-
Motivations, Expectations, and Decision-making of Sickle Cell Patients in Clinical Research
NCT03709303 ·Status: COMPLETED
-
Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
NCT06818266 ·Status: RECRUITING ·Phase: PHASE3
-
Long-term Endurance Training in Sickle Cell Disease Patients: Impact on Clinical Profile, Physical Fitness, and Quality of Life.
NCT06823219 ·Status: RECRUITING ·Phase: NA